|
2024
|
Invention
|
Single domain antibody against serpin a12 and use thereof. The present invention relates to a sin... |
|
2023
|
Invention
|
Biomarkers for predicting the treatment efficacy of gpcr19 agonists in the treatment of atopic de... |
|
|
Invention
|
Bispecific humanized single domain antibody to pd-l1 and cd47, and use thereof. in vitroin vivoin... |
|
|
Invention
|
Composition for preventing or treating pulmonary fibrosis, comprising taurodeoxycholic acid or ph... |
|
2022
|
Invention
|
Composition containing taurodeoxycholic acid or pharmaceutically acceptable salt thereof as activ... |
|
|
Invention
|
Pharmaceutical composition for preventing, alleviating or treating nonalcoholic steatohepatitis a... |
|
|
Invention
|
Pharmaceutical composition comprising inflammasome inhibitor as active ingredient for prevention,... |
|
|
Invention
|
Composition for treating coronavirus disease 2019 (covid-19) containing taurodeoxycholic acid or ... |
|
|
Invention
|
Gel composition for preventing or treating atopic dermatitis. The present invention relates to a ... |
|
|
Invention
|
Pharmaceutical composition for ameliorating or treating chronic skin diseases. The present invent... |
|
|
Invention
|
Gel composition for prevention or treatment of atopic dermatitis. The present invention relates t... |
|
|
Invention
|
Novel compound that inhibits tnf-alpha generation and inflammasome activity and preparation metho... |
|
|
Invention
|
Novel compound that inhibits tnf-a generation and inflammasome activity and preparation method th... |
|
|
Invention
|
Composition for treatment of covid-19 comprising taurodeoxycholic acid or pharmaceutically accept... |
|
|
G/S
|
Food for infants |
|
|
Invention
|
Single domain antibody against pd-l1 and use thereof.
The present invention relates to a single ... |
|
|
Invention
|
Bispecific single domain antibody to pd-l1 and cd47 and use thereof.
The present invention relat... |
|
|
Invention
|
Single domain antibody against cd47 and use thereof.
The present invention relates to a single d... |
|
|
Invention
|
Single domain antibody against cd47 and use thereof. The present invention relates to a single do... |
|
|
Invention
|
Bispecific single domain antibody to pd-l1 and cd47 and use thereof. The present invention relate... |
|
|
Invention
|
Single domain antibody against pd-l1 and use thereof. The present invention relates to a single d... |
|
|
G/S
|
biological preparations for medical or veterinary purposes; biochemical preparations for medical ... |
|
2021
|
Invention
|
Single domain antibody against sars-cov-2, and use thereof. The present invention relates to a si... |
|
|
Invention
|
Gpcr19-p2xn receptor complex and use thereof.
The present invention relates to a GPCR19-P2Xn rec... |
|
|
Invention
|
Method for mass-producing sodium taurodeoxycholate.
The present invention relates to a mass prod... |
|
|
Invention
|
Pharmaceutical composition for treating nonalcoholic steatohepatitis and liver fibrosis. The pres... |
|
|
Invention
|
Gpcr19-p2xn receptor complex and use thereof. The present invention relates to a complex of GPCR1... |
|
|
Invention
|
Method for mass-producing sodium taurodeoxycholate. The present invention relates to a method for... |
|
2020
|
Invention
|
Composition for preventing or treating inflammatory bowel disease, containing, as active ingredie... |
|
2018
|
Invention
|
Pharmaceutical composition for prevention, treatment or delay of alzheimer's disease or dementia ... |
|
2017
|
Invention
|
Composition comprising gpcr19 agonist as an active ingredient for preventing or treating allergic... |
|
2016
|
Invention
|
Composition for inhibiting myeloid-derived suppressor cells comprising decitabine or its pharmace... |
|
2009
|
Invention
|
Use of biological surfactant as anti-inflammatory agent and tissue preservative solution. The pre... |
